GSK begins U.S. test of experimental drug for pneumonia from COVID-19

GlaxoSmithKline (GSK) has started a trial in the United States to test an experimental rheumatoid arthritis drug on patients suffering from pneumonia caused by COVID-19, the British drugmaker said on Tuesday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.